Westminster International Ltd
Letter data
- Company
- Westminster International Ltd
- Recipient
- Peter Fowler | Westminster International Ltd | Westminster House, Blacklocks Hill (Banbury Lane) | Banbury, Oxfordshire | OX17 2BS | United Kingdom | p.fowler@wg-plc.com
- Issue date
- 2025-03-25
- Posted date
- Not available
- FDA office
- Center for Devices and Radiological Health
- Subject
- Not available
- Product
- Medical Devices
- CMS ID
- 613566
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Westminster International Ltd
MARCS-CMS 613566 —
March 25, 2025
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Product:
Medical Devices
Recipient:
Recipient Name
Peter Fowler
Westminster International Ltd
Westminster House, Blacklocks Hill (Banbury Lane)
Banbury, Oxfordshire
OX17 2BS
United Kingdom
p.fowler@wg-plc.com
Issuing Office:
Center for Devices and Radiological Health
United States
Secondary Issuing Offices
United States
Dear Peter Fowler:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter CMS# 613566, dated March 4, 2021. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Michael J. Hoffmann
Director
Office of Health Technologies 3 - Gastrorenal, ObGyn,
General Hospital, and Urology Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Food and Drug Administration
Content current as of:
03/31/2025
Regulated Product(s)
Medical Devices